Study of P-glycoprotein in Multidrug Resistant Mouse Tumor Cells
Author Information
Author(s): M.A. Barrand, P.R. Twentyman
Primary Institution: MRC Clinical Oncology and Radiotherapeutics Unit
Hypothesis
The study aims to evaluate the reactivity of different monoclonal antibodies against P-glycoprotein in multidrug resistant mouse tumor cell lines.
Conclusion
Different monoclonal antibodies recognize distinct P-glycoprotein isoforms in mouse tumor cells, indicating variations in drug resistance mechanisms.
Supporting Evidence
- C219 antibody stained resistant variants of both human and mouse tumor cell lines.
- MRK 16 and JSB-1 recognized P-glycoprotein only in human MDR cell lines.
- 265/F4 antibody was selective for the mdrlb P-glycoprotein in mouse cells.
Takeaway
Scientists looked at how different antibodies can see a protein that helps cancer cells resist drugs, and they found that some antibodies work better on certain types of cancer cells.
Methodology
The study used immunocytochemical methods, Western blotting, and PCR to analyze P-glycoprotein expression in various mouse and human tumor cell lines.
Limitations
The study primarily focuses on specific monoclonal antibodies and may not encompass all aspects of multidrug resistance.
Want to read the original?
Access the complete publication on the publisher's website